Ultra-sensitive genomic analysis platform
Our cutting-edge SmartRD platform delivers multi-omic analysis with unparalleled genomic expertise and cost-effectiveness.
SmartRD Platform
An ultra high sensitivity multi-modal liquid biopsy platform that transforms cancer monitoring and treatment development.
Ultra Deep Sequencing
Cell-free (cf) DNA sequencing and analysis with unparalleled depth and sensitivity
Unique Epigenetic Data
Comprehensive methylation and nucleosome profiling for deeper biological insights
AI/ML Platform
Proprietary computational platform for advanced analysis and biomarker discovery
Key Technologies
Breakthrough innovations published in leading scientific journals
cfDNA Sequencing
In-depth cfDNA analysis for treatment efficacy assessment, clonal evolution and resistance dynamics for biomarker discovery, revealing signal from all lesions.
Nature Medicine 2019Subclonal Reconstruction
Evolution and resistance analysis reveals latent trends invisible from bulk analysis, increasing statistical power in small cohorts.
Nature Medicine 2023Early Driver Identification
Establish previously unknown early genetic progression of cancers for early detection, interception and prognostication.
Nature Cancer 2024Research Capabilities
Comprehensive genomic analysis services for cancer research and drug development
DNA Sequencing & Analysis
Comprehensive variant analysis, population genetics, and genome-wide association studies. From WGS to targeted sequencing, we provide deep insights into genetic variation and mutations.
- •Whole-genome and exome sequencing
- •Somatic and heritable variant analysis
- •Copy-number and structural variants
Single-Cell RNA Analysis
Catalog and study cellular identities at unprecedented resolution. Integration with scATAC-seq, proteomics, and spatial transcriptomics for comprehensive insights.
- •Cell type identification and characterization
- •Trajectory and pseudotime analysis
- •Ligand-receptor interaction networks
Circulating Tumor DNA
Real-time, non-invasive detection of tumor response and minimal residual disease (MRD) monitoring for treatment development and patient stratification.
- •MRD detection and monitoring
- •Treatment response assessment
- •Biomarker discovery
Tumor Evolution Analysis
Understand cancer heterogeneity, clonal evolution, and resistance mechanisms through advanced computational methods and AI/ML approaches.
- •Subclonal reconstruction
- •Resistance prediction
- •Evolutionary trajectory mapping